Clinical trials, adaptability and the COVID-19 pandemic

• Published in: Gynecologic oncology reports Vol. 35; p. 100680
• Main Authors: Eskander, Ramez N., Pothuri, Bhavana, Randall, Leslie, O'Malley, David, Slomovitz, Brian, Moore, Kathleen, Coleman, Robert, Herzog, Thomas, Monk, Bradley J., Copeland, Larry
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-02-2021; Elsevier
• Subjects: Adaptability; Clinical trials; COVID-19; Gynecologic cancer; Pandemic; Short Communication; COVID-19; Clinical trials; Pandemic; Gynecologic cancer; Adaptability
• ISSN: 2352-5789; 2352-5789
• DOI: 10.1016/j.gore.2020.100680

•The COVID-19 pandemic has required adaptability in the workplace.•Women health care professionals are disproportionately affected by the burdens resulting from the pandemic.•Flexible work options are critical to ensure staff have the resources to provide cancer care and clinical trial options.
Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.